Zydus Lifesci.

48
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE010B01027
  • NSEID: ZYDUSLIFE
  • BSEID: 532321
INR
931.45
-4.3 (-0.46%)
BSENSE

Dec 05

BSE+NSE Vol: 9.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Zydus Lifesci. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
6,026.00
4,838.00
2,582.00
5,232.00
2,284.00
1,495.00
Adjustment
1,020.00
546.00
933.00
-2,117.00
1,163.00
1,474.00
Changes In working Capital
1,531.00
-902.00
-235.00
-336.00
191.00
263.00
Cash Flow after changes in Working Capital
8,578.00
4,482.00
3,280.00
2,779.00
3,638.00
3,233.00
Cash Flow from Operating Activities
6,776.00
3,196.00
2,688.00
2,104.00
3,293.00
2,931.00
Cash Flow from Investing Activities
-8,377.00
-1,492.00
1,541.00
-1,017.00
-836.00
-1,004.00
Cash Flow from Financing Activities
2,014.00
-1,778.00
-4,400.00
-868.00
-2,547.00
-1,528.00
Net Cash Inflow / Outflow
413.00
-74.00
-170.00
218.00
-90.00
398.00
Opening Cash & Cash Equivalents
413.00
487.00
657.00
888.00
1,177.00
778.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
826.00
413.00
487.00
1,106.00
1,087.00
1,177.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Zydus Lifesci.
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
6026.7
4015
2,011.00
50.10%
Adjustment
1020.4
1301.52
-281.00
-21.60%
Changes In working Capital
1531.5
-1410.54
2,941.00
208.58%
Cash Flow after changes in Working Capital
8578.6
3905.98
4,673.00
119.63%
Cash Flow from Operating Activities
6776.7
2999.94
3,777.00
125.89%
Cash Flow from Investing Activities
-8377.1
-4171.89
-4,206.00
-100.80%
Cash Flow from Financing Activities
2014.2
1731.88
283.00
16.30%
Net Cash Inflow / Outflow
413.8
559.93
-146.00
-26.10%
Opening Cash & Cash Equivalents
413
983.76
-570.00
-58.02%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
826.8
1543.69
-717.00
-46.44%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 112.02% vs 18.87% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
6,776.70
3,196.30
112.02%